Refresh

Bal Pharma Ltd. - Research Center

524824 BALPHARMA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

303.10 280.37 249.31 170.67 223.08
Expenses

Material consumed

170.39 166.77 150.83 84.54 117.23

Manufacturing expenses

6.71 5.37 4.70 1.14 2.74

Personnel expenses

51.91 44.46 39.62 48.77 48.45

Selling expenses

2.90 2.22 1.41 3.19 2.62

Adminstrative expenses

45.16 38.35 26.43 26.28 31.73

Expenses capitalised

- - - - -

Cost of sales

277.07 257.16 222.99 163.92 202.77

Operating profit

26.03 23.20 26.32 6.75 20.31

Other recurring income

2.15 6.49 2.69 3.62 2.75

Adjusted PBDIT

28.19 29.69 29.01 10.37 23.05

Financial expenses

12.16 10.40 11.96 12.42 12.53

Depreciation

7.48 7.24 7.26 7.03 6.12

Other write offs

- - - - -

Adjusted PBT

8.55 12.06 9.80 -9.08 4.41

Tax charges

2.42 3.48 0.70 -0.17 -2.35

Adjusted PAT

6.13 8.58 9.10 -8.90 6.76

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

6.13 8.58 9.10 -8.90 6.76

Earnigs before appropriation

48.49 43.85 35.27 27.88 38.49

Equity dividend

1.56 1.48 - 1.13 1.71

Preference dividend

- - - - -

Dividend tax

- - - 0.29 -

Retained earnings

46.94 42.37 35.27 26.47 36.79
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com